Physician profile
John Manning
NPI 1477964146
$36,784.91
in general payments reported to CMS, 2019-2025
11 companies · $425 in 2025
The $425 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $22K · 2021: $1,680 · 2023: $1,126 · 2024: $256 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,035 · Food and Beverage: $772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,034.59 |
| Food and Beverage | $772.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $30,408.06 | 2019-2021 | |
| Summit Surgical Corp. | $2,460.06 | 2020-2021 | |
| Stryker Corporation | $1,862.47 | 2019-2023 | Salvation, Iconix, Hoffmann |
| Micromed INC | $1,248.00 | 2019-2020 | |
| Miach Orthopaedics, INC. | $535.51 | 2024-2025 | |
| Smith+Nephew, INC. | $116.63 | 2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Medtronic USA, INC. | $50.00 | 2019 | |
| Depuy Synthes Sales INC. | $29.85 | 2019 | |
| Invictus Surgical Incorporated | $29.08 | 2025 | |
| Wright Medical Technology, INC. | $24.57 | 2019 | |
| Si-Bone, INC. | $20.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Manning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.